DICOT AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2495 SEK | +3.96% |
|
-6.38% | -21.54% |
| May. 06 | Dicot AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Apr. 23 | Dicot AB Announces Positive Safety and Improved Efficacy Results from Phase 1 Study | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| Sales 2022 | - | Sales 2023 | - | Capitalization | 260M 23.98M |
|---|---|---|---|---|---|
| Net income 2022 | -31M -2.86M | Net income 2023 | -44M -4.06M | EV / Sales 2022 | - |
| Net cash position 2022 | 9.38M 865K | Net cash position 2023 | 47.34M 4.37M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-1.27
x | P/E ratio 2023 |
-3.81
x | Employees | 3 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 0% |
More Fundamentals
* Assessed data
More news
| 1 day | +3.96% | ||
| 1 week | -6.38% | ||
| 1 month | -11.05% | ||
| 3 months | +9.91% | ||
| 6 months | +126.82% | ||
| Current year | -21.54% |
1 week
0.24
0.27
1 month
0.200.29
Current year
0.170.42
1 year
0.100.42
3 years
0.101.20
5 years
0.106.90
10 years
0.1011.50
| Managers | Title | Age | Since |
|---|---|---|---|
Elin Trampe
CEO | Chief Executive Officer | - | 21-08-31 |
Björn Petersson
DFI | Director of Finance/CFO | 63 | 22-03-06 |
| Chief Tech/Sci/R&D Officer | 53 | 22-07-10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Michael Zell
BRD | Director/Board Member | - | 21-12-31 |
| Director/Board Member | 79 | 22-12-31 | |
| Director/Board Member | 68 | 21-05-26 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-10 | 0.265 | +6.21% | 2,520,255 |
| 24-05-08 | 0.2495 | +3.96% | 1,267,504 |
| 24-05-07 | 0.24 | -5.51% | 3,429,912 |
| 24-05-06 | 0.254 | -5.22% | 1,867,526 |
| 24-05-03 | 0.268 | +0.56% | 2,127,031 |
End-of-day quote NORDIC GROWTH MARKET, May 07, 2024
More quotes
Dicot AB is a manufacturer of pharmaceutical preparation. The Company is located in Uppsala, Sweden.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -21.54% | 19.99M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
- Stock Market
- Equities
- DICOT Stock
